Third, TCGA transcriptomic data that have been used to study the tumor immune infiltration26 can also be integrated with our network MHC I-association prediction (Fig. 1c) to identify genes and pathways that are associated with tumor response to anti-PD-1 therapy in a given cancer type. This evidence concerns the gene PDCD1 and cancer.